A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Care in Patients With Advanced Cancer: a Pilot Clinical Trial
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT07246954
- Status
- Recruiting
Conditions
- Advanced Cancer
- Spiritual Care
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Peace Intervention — OTHERPatients will participate in two PEACE intervention sessions, which will last 30-60 minutes each.
- Usual Care — OTHERUsual care is a comprehensive evaluation of the physical, emotional, and spiritual needs of the patient by the Supportive/Palliative Care medical team.
Study Details
To examine the feasibility and acceptability of chaplain-clinician led spiritual care (PEACE: Perception, Exploring, Addressing, Compassionate Connection, Embracing) intervention in patients with advanced cancer.
Key Dates
- Start date
- Dec 22, 2025
- Status verified
- Apr 2026
- Primary completion
- Jan 1, 2027
- Completion
- Jan 1, 2029
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Phase 1Patients will participate in two PEACE intervention sessions, which will last 30-60 minutes each.
- Experimental: Phase 2Usual care is a comprehensive evaluation of the physical, emotional, and spiritual needs of the patient by the Supportive/Palliative Care medical team
Primary Outcome Measure
RBEC Questionnaire [ Time Frame: Through study completion; an average of 1 year ]
Central Contacts
- Marvin Delgado Guay, MD713-745-8190
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 | Marvin Delgado Guay, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site
Related Studies
- Psychophysical Studies of Cancer Therapy PainRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · Artios Pharma Ltd · Birmingham, Alabama
- Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsPHASE1 · Recruiting · I-Mab Biopharma US Limited · Orange, California
- Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid TumorsPHASE1 · Recruiting · Riboscience, LLC. · Scottsdale, Arizona